There are three primary ways we can help you find talent, discover technologies and build your brand among young scientists:
Expertise in the next generation of therapeutic technologies lies with young academic scientists. These scientists are incredibly talented but underserved by existing career development programs.
A little bit of help goes a long way -- and will be remembered for the rest of their careers.
Bay Bridge Bio is often these scientists' first exposure to the biopharma industry. Alums have joined leading venture funds, consulting groups, and startup companies.
Projects tend to focus on outside-the-box technologies at the intersection of biology and engineering: engineered therapies targeting the tumor glycode, autophagy modulators for cancer and cardiovascular disease, next-generation "living" therapies. "Beginner's mind" + fluency in emerging tech + guidance from experienced professionals = "why didn't I think of that?"
Biotech VCs focus on experienced entrepreneurs. Tech VCs focus on software engineers and data scientists. No one is funding young biologists and bioengineers.
But historically, young CEOs and scientists have started most of the lasting biotech companies.
Read why we think the time is right for young biotech founders.